高度な甲状腺がんに対する全身療法 - 新しいパーソナライズされた選択肢
1Thyroid Unit, The Royal Marsden NHS Foundation Trust, 203 Fulham Road, London, SW3 6JJ, United Kingdom. lesliecheng@nhs.net.
Drugs
|August 29, 2025
まとめ
タイロシンキナーゼ阻害剤 (TKI) は 進行した甲状腺がんの治療に 変化をもたらしました 分子検査による標的治療は,放射性ヨウ素耐性差異性甲状腺がん,アナプラスティック甲状腺がん,髄膜性甲状腺がんの生存率を向上させます.
科学分野:
- 腫瘍学
- 薬理学について
- 遺伝学
背景:
- 進行した甲状腺がん (RR-DTC,ATC,MTC) は,従来の化学療法に対する反応が弱い.
- ティロシンキナーゼ阻害剤 (TKI) は,これらの攻撃的な悪性腫瘍に対する全身療法におけるパラダイムシフトを表しています.
- ゲノムプロファイリングによる パーソナライズド医療は 甲状腺がん治療の 中心的な役割を果たしています
研究 の 目的:
- 進行した甲状腺がんに対する薬物療法の有効性と安全性に関する現在の証拠をレビューする.
- パーソナライズされた標的治療の役割を探求する
- 分子テストと次世代配列の影響を強調する
主な方法:
- 甲状腺がんの薬物療法に関する現代的な証拠のレビュー.
- マルチキナーゼ阻害剤 (MKIs) と標的型療法に関する臨床試験データの分析
- 分子検査 (例えば次世代シーケンシング) を治療決定に統合する検討
主要な成果:
- マルチキナーゼ阻害剤 (ソラフェニブ,レンバチニブ,ヴァンデタニブ,カボザンチニブ) は,RR-DTCおよびMTCにおける無進行生存率と応答率を改善します.
- BRAF V600E変異を有するアナプラスティック甲状腺がんでは,生存率を向上させる.
- RET,NTRK,その他の変異を標的とする高度選択的阻害剤は,腫瘍遺伝学に基づく治療を精製する.
結論:
- 甲状腺がんの治療に革命を起こし 改善された結果をもたらしました
- 分子検査は 個別的な治療選択や 個々の腫瘍のプロファイルに合わせた治療に不可欠です
- 薬剤耐性,毒性,分子診断と標的治療への公平なアクセスなどの課題は残っており,さらなる研究が必要である.
関連する概念動画
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Synthesis and Regulation of Thyroid Hormones
5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K


